Tranexamic Acid

Injury

Daniel Nishijima, MD, MASSmall moleculePhase 3Active

BB

66/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 52/ 100
Competitive Position: 95/ 100

Competitive context

7 Active assets in the Injury cohort.

Asset / Sponsor	Phase	Rating
TESTOSTERONE UNDECYLATE Craig Hospital	Phase 4	BB
GLUCOSE, ANHYDROUS Baskent University	Phase 4	BB
Midazolam Baskent University	Phase 4	BB
Apsolol Hamad Medical Corporation	Phase 4	BB
Epoetin Alfa Australian and New Zealand Intensive Care Research Centre	Phase 3	B

View all 29 →

Same molecule, other indications

Tranexamic Acid is also rated in:

intracerebral hemorrhageActive

BB

Indicative · Phase 4

71 / 100

post-operative wound seroma, non-human animalDormant

BB

Indicative · Phase 4

69 / 100

brain injuryDormant

BB

Indicative · Phase 3

68 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.